Compare ONEW & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONEW | CVRX |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.4M | 171.7M |
| IPO Year | 2019 | 2021 |
| Metric | ONEW | CVRX |
|---|---|---|
| Price | $10.28 | $7.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $16.75 | $11.20 |
| AVG Volume (30 Days) | 125.9K | ★ 422.3K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ 2.77 | N/A |
| Revenue | ★ $1,872,334,000.00 | $56,651,000.00 |
| Revenue This Year | N/A | $16.78 |
| Revenue Next Year | $3.27 | $19.73 |
| P/E Ratio | $3.58 | ★ N/A |
| Revenue Growth | 5.62 | ★ 10.45 |
| 52 Week Low | $9.79 | $4.37 |
| 52 Week High | $18.15 | $13.34 |
| Indicator | ONEW | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 35.53 | 52.86 |
| Support Level | N/A | $6.76 |
| Resistance Level | $12.51 | $8.13 |
| Average True Range (ATR) | 0.67 | 0.61 |
| MACD | -0.21 | 0.11 |
| Stochastic Oscillator | 32.24 | 69.51 |
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.